Use of the 1.5T Elekta Unity MR-Linac was associated with reduced rates of erectile dysfunction at 6, 12, and 18 months in ...

Treatment-related adverse effects were reported in 97.2% of heavily pretreated patients with uterine serous carcinoma taking ...

Panelists discuss how innovative approaches to symptom monitoring incorporate multifaceted technology and team-based strategies, including electronic patient-reported outcome tools integrated with ...

Video content above is prompted by the following: The Oncology Nursing News program focuses on treatment strategies for ESR1-mutant hormone receptor-positive, HER2-negative breast cancer. Led by ...

The Oncology Nursing News program focuses on treatment strategies for ESR1 -mutant hormone receptor-positive, HER2-negative breast cancer. Led by Tiffany A. Traina, MD, FASCO, from Memorial Sloan ...

A nurse practitioner gives her advice for managing adverse events during treatment with talquetamab for multiple myeloma.

Traditionally, HER2 status has been determined by immunohistochemistry (IHC) and in situ hybridization (ISH), distinguishing ...

The amount of CDK4/6-targeting treatment options available for patients with HR-positive breast cancer allows providers to ...

Toilet Cover May Significantly Reduce Aerosol Exposure in Hospital Bathrooms ...